Ocimum Bio Buys Gene Logic's Genomic Business For $10 Million

Hyderabad based Ocimum Biosolutions today announced that it has agreed to buy Maryland, US-based Gene Logic's Genomics Business for $10 million in cash. The purchase includes Gene Logic's knowledge products business. They include the genomic database (BioExpress) and other programmes like ToxExpress, Genesis software system and web-enabled products like Ascenta, Sciantis and ToxShield.
As part of the transaction, Ocimum has also acquired Gene Logic's genomic and genetic services business.
Investment bank O3 Capital advised Ocimum on the deal. Ocimum will continue to operate the business out of the current state-of-the-art laboratory facility in Gaithersburg, Maryland. World Bank private equity arm International Finance Corporation had invested $6.5 million in Ocimum last year.

Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

BY INVITATION
ColumnistImage

India: The World’s Biggest Small Company

ColumnistImage

Tips For Entrepreneurs To Raise Money In An Overheated Market

Untitled 1


INSIGHT

The Dilemma Of “Control”

NARENDRA DINGANKAR & MINI RAMAN
In India, law governing acquisition of “control” of listed cos is laid out in takeover regulations framed by SEBI.
About 60 fund managers polled for the VCCircle Survey.